PATIENT EDUCATION
What is a cataract?
A cataract is clouding of the lens in the eye. The lens is the part of the eye that focuses light (figure 1). Cataracts can cause vision loss.
What are the symptoms of cataracts?
Cataracts make a person’s vision blurry or dull (picture 1). They can also make everything look slightly brown in color. Some people notice a problem when they keep needing new eyeglass prescriptions. For some, headlights and other lights might seem to have a glare.
Is there a test for cataracts?
Yes. Your doctor or nurse might be able to see your cataracts just by looking in your eye. But if it looks like you have cataracts, your doctor or nurse will probably send you to an eye doctor. Eye doctors can usually diagnose cataracts in minutes.
If you have vision loss, it could be caused by more than 1 thing. An eye doctor can check you for the most common causes of vision loss by doing a “comprehensive eye exam.” During the exam, the doctor will:
- Check how well you see things up close and far away
- Check how well you see things that are at the center of focus, and how well you see things that are off to the sides
- Measure the pressure inside of your eye using a special device
- Look into the back of your eyes to check for signs of nerve damage
How are cataracts treated?
The main treatment for cataracts with major vision loss is surgery. This involves removing the cloudy lens and replacing it with a new artificial one. Not everyone needs treatment. If you have cataracts, you decide if and when to have surgery.
Cataract surgery is pretty simple, although rarely, it can lead to problems such as infection or pain. But the surgery can greatly improve vision in people with severe cataracts.
How do I decide about surgery?
If you are thinking about surgery, ask your doctor:
- What are the risks of surgery for me? (If you have any other health problems, ask how they might affect the results of the surgery.)
- How much is my vision likely to improve if I have the surgery?
- Is it possible that the surgery will not work?
- Are my cataracts the only thing causing my vision problems? (If you have other eye conditions, surgery might not help with those.)
- What will recovery be like?
If you need cataract surgery in both eyes, it will often be done as 2 separate procedures on different days. In some cases, both procedures can be done on the same day.
After you get all of this information from your doctor, ask yourself:
- How much do my vision problems limit me?
- Can I do all of the things I need to do with the vision I have left?
- Have I stopped doing things I love, such as reading or knitting, because I can’t see well anymore?
- How do I feel about the possible risks of surgery?
- How will I feel if the surgery causes problems or does not work?
- Will there be someone who can help me while I recover?
Think about these things. Then, work with your doctor to decide whether surgery is right for you.
Can cataracts be prevented?
You can reduce your chances of getting cataracts by not smoking or quitting if you do smoke.
References
How well you feel when you are on hemodialysis will depend on:
- Eating the Right kind and amounts of food.
- Controlling your fluid intake
- Attending and completing all your scheduled hemodialysis treatments
- Taking the medicines prescribed by your Kidney Doctors.
Why do I need a special diet?
Your diet is an important part of your overall treatment. Your kidneys are not working; thus, you cannot get rid of enough waste products and fluids from your body, thus you will need to limit fluids, and change your intake of certain foods in your diets.
In general, you will need to
EAT MORE (high protein foods)
EAT LESS (high salt, high potassium, and high phosphorus foods).
ADJUST AND CONTROL (the amount of fluid you can safely drink in a day).
Overall, a balanced plate is important:
For each meal, include something from these food groups:
- Protein foods – fish, poultry, meat, eggs,
- Starchy foods – bread, cereal, rice, noodles
- Fruits and Vegetables – have a variety
Each person’s diet may be different depending on his or her blood test results. If you need further advice with regards to your diet and what food you can eat, please let your Hemodialysis Team know, and we will be happy to get you in touch with a Dietitian.
What will my diet look like?
Individualized, depending on your blood test results, you may need to learn and focus more about:
- Protein
- Phosphorous
- Sodium
- Fluid
- Potassium
Protein
Do I need more protein?
People on dialysis need to eat more protein. During Dialysis you lose some protein. Protein is important to help keep your muscles strong, help wounds heal faster, strengthen your immune system, and helps improve overall health.
Eat protein-rich foods, eggs, fresh chicken/beef, fresh fish.
- Avoid processed meats such as sausages, canned meat (corned beef), canned sardines, hot dogs, fish fingers, chicken nuggets, and smoked or dried meat or fish.
- Some high protein foods such as peanut butter, nuts, seeds, dried beans, peas, and lentils are generally limited because they are high in both potassium and phosphorus.
Phosphorous
What is phosphorous?
Phosphorous is a mineral. It works with calcium to keep your bones and teeth strong. Dialysis helps remove some phosphorous from your blood.
High Phosphorus levels in your blood may cause:
- hardening of your blood vessels
- Weak and easily broken bones.
- Bone, joint, and muscle pain
- Itch
How to control your phosphorous level?
- Dialysis – complete all your dialysis treatments.
- Diet – Eat a diet lower in phosphorus.
- Phosphorus Binders – if prescribed, take with meals.
What food is high in phosphorus?
Some food naturally contains phosphorous such as milk, cheese, yoghurt, nuts, and some foods had phosphorous added to them such as cola beverages, fast foods, canned foods, and processed meats.
People on dialysis are advice to avoid “whole grain” and “high fiber” foods (like whole wheat bread, bran cereal, and brown rice) to help limit intake of phosphorous.
Rice and almond milk are low in phosphorus and can be used as alternatives to dairy milk.
Phosphorous is added to some foods and beverages during processing. Be sure to read food ingredient labels.
What are phosphorous binders?
Phosphorous-binding medications help manage phosphorous levels in your body. Some of the types of phosphorous binders that you may be on:
- Calcium Carbonate
- Sevelamer Carbonate
Phosphorous binder should be taken with food. If you forget to eat them, take them within 30 minutes of eating.
Sodium
Sodium is a mineral found in most foods. Sodium is important for water balance in the body. However, too much salt can cause a lot of problems in dialysis patients: high blood pressure, swelling/puffiness, increased thirst.
Advisable to use less salt and eat less salty food: This may help to control blood pressure. It may also help reduce fluid weight gain between dialysis sessions since salt increases thirst and causes the body to retain (or hold on to) fluid.
How can I eat less sodium?
- Prepare and cook your food at home more often (Outside food from restaurants, or fast-food meals have higher sodium content than home-cooked meals.)
- Avoid high sodium packaged, convenience or processed foods such as:
- Salted Fish
- Dried Shrimp (Udang Kering), ‘Belacan’, bubuk
- Small Dried Fish (Ikan kering – ‘Pusu’, ‘tamban’, ‘tahai’
- Pickles/Samboi/Salted Vegetables
- Instant Soup (packaged)
- Organ meats
- Flavoring sachets or stock cubes
- Instant noodles
- Read Food Labels. Avoid ingredients such as Monosodium glutamate (MSG), Baking soda, soya sauce, and sodium
- Avoid adding high salt content sauces to food: Tomato Sauce, BBQ Sauce, Soy Sauce (Kicap), Oyster Sauce.
How to add flavor without adding salt?
Season your food with:
- Fresh herbs.
- Garlic, Ginger, Onion
- Spices – Advised to use whole spices, fresh spices, and not to use curry and powdered spices.
Fluid
Why do I need to limit my fluid intake?
If you make very little or no urine, the fluid you drink will stay in your body.
Too much fluid can cause:
- High Blood Pressure
- Fluid in the lungs, making it hard to breathe.
- Puffy hands, face, and feet
- Extra work for your heart which can lead to heart failure.
- Cramping on dialysis
- Large weight gains between dialysis runs.
How much fluid can I drink?
The amount you can drink depends on how much urine you make.
Per day fluid intake can range between 500ml to 1L. The amount of fluid intake will depend on each individual and advice from your kidney doctor.
What counts as fluid?
Any food items that can melt or are liquid at room temperature will be calculated into part of your daily fluid intake.
For example, water, ice, tea, and coffee, milk, soups, ice cream, jelly, soda.
Some tips to reduce fluid intake:
- Choose lower-sodium foods – this will help reduce thirst.
- Maintain good blood sugar control, high blood sugars will cause thirst.
- Choose smaller cups. Your usual cup may hold more fluid than you think.
- Use small amounts of water to take pills.
Potassium
What is potassium?
Potassium is a mineral found in most foods. In your body, it helps your nerves, muscles, and heart to work properly. When your kidneys are not working, you cannot remove potassium easily from the body. People on hemodialysis need to keep their potassium level in a safe range.
High Potassium may cause:
- numbness or tingling in hands and feet.
- Weak muscles
- Irregular heartbeat
- Your heart to stop.
How can I control my potassium?
- Dialysis – Attend your dialysis and complete your
- Bowel Habits – Avoid constipation
- Exercise – Plan to be active every
- Serving sizes are important: A large portion of low-potassium food can become a high source of potassium.
- Diet – Read food labels. Avoid foods with potassium additives.
- Potassium additives are identified by the word potassium in the ingredient e.g., Potassium Chloride, Potassium Phosphate, Potassium lactate, Potassium Citrate.
- Example of foods containing potassium additives: processed meats and cheese, electrolyte beverages, instant or powdered beverages (3 in 1 coffee or tea mixes), canned soups and broths.
- How you prepare and cook your food can help to reduce potassium.
- Boiling root vegetables can help remove some potassium from the food into the cooking water. Discard cooking water.
- Soak green leafy vegetables for 2 hours prior to cooking.
Examples of high-potassium foods to avoid
- All vegetable and fruit juices
- Kiwi
- Tomato puree
- Melon – rock, honeydew
- Banana
- Dried fruit- raisin, mixed dried fruit
- Durian
- Dates (Kurma)
- Avocado
- Grapefruit
- Guava
- Soursop
- Pomelo
- Apricot
- Lentils/dahl/dried or tinned beans – chickpeas, kidney beans
- Rambutan
- Coconut products- milk, cream, water, or flesh
- Commercially prepared potato products – chips
Note: Always avoid Star Fruit.
Examples of suitable Vegetables that can be eaten at daily meals
- Cabbage
- Carrot
- Cucumber
- Cauliflower
- Bamboo shoot (rebong)
- Turnip (‘sengkuang’)
- Egg plant (‘terung’)
- Asparagus
- Lettuce/salad
- Marrow (‘Labu Air’)
- Pumpkin (‘labu kuning’)
- Broccoli
- Green leafy vegetables (‘sawi’, ‘bayam’, ‘kangkong’)
- Radish (Labu putih)
- Chinese cabbage
- Mushroom (fresh or canned)
- Corn (fresh, tinned, or young)
- Mixed vegetables containing a mixture of the allowed vegetables
- Local green vegetables (Lemiding, pakis, ulam-ulam)
Note: Vegetables are advised to be peeled, chopped, and soaked for 2 hours in water before cooking. Water used for soaking the vegetables should be discarded.
References:
National Kidney Foundation (https://www.kidney.org/)
National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/hemodialysis/eating-nutrition)
BCRenal (http://www.bcrenal.ca/)
Introduction
Cholecystectomy is one of the most commonly performed abdominal surgical procedures, and in developed countries many are performed laparoscopically. As an example, 90 percent of cholecystectomies in the United States are performed laparoscopically [1]. Laparoscopic cholecystectomy is considered the “gold standard” for the surgical treatment of gallstone disease. This procedure results in less postoperative pain, better cosmesis, and shorter hospital stays and disability from work than open cholecystectomy [2-8]. However, the overall serious complication rate in laparoscopic cholecystectomy remains higher than that seen in open cholecystectomy [9,10]. (See “Complications of laparoscopic cholecystectomy”.)
This topic will discuss the technique of a routine laparoscopic cholecystectomy. Additional techniques that may be required to treat an inflamed gallbladder or common bile duct stone are discussed separately. (See “Managing the difficult gallbladder” and “Surgical common bile duct exploration”.)
The diagnosis and overall treatment approach to cholecystitis is discussed elsewhere in detail. (See “Acute calculous cholecystitis: Clinical features and diagnosis” and “Treatment of acute calculous cholecystitis”.)
Indications
The indications for laparoscopic cholecystectomy are the same as for open cholecystectomy:
- Symptomatic cholelithiasis with or without complications. (See “Treatment of acute calculous cholecystitis” and “Overview of gallstone disease in adults”.)
- Asymptomatic cholelithiasis in patients who are at increased risk for gallbladder carcinoma or gallstone complications. (See “Approach to the management of gallstones”.)
- Acalculous cholecystitis. (See “Acalculous cholecystitis: Clinical manifestations, diagnosis, and management”.)
- Gallbladder polyps >0.5 cm. (See “Gallbladder polyps”.)
- Porcelain gallbladder. (See “Porcelain gallbladder”.)
Contraindications
Contraindications to laparoscopic cholecystectomy are primarily related to anesthetic concerns and include diffuse peritonitis with hemodynamic compromise and uncontrolled bleeding disorders [11]. The inability to tolerate general anesthesia is considered a relative contraindication, but successful laparoscopic cholecystectomy under spinal anesthesia has been reported [12].
If there is suspicion of gallbladder cancer, open cholecystectomy should be performed [13]. (See “Prognosis and adjuvant treatment for localized, resected gallbladder cancer”.)
Relative contraindications are dependent on the surgeon’s judgment and experience but include patients with previous extensive abdominal surgery, cirrhosis with portal hypertension, severe cardiopulmonary disease, active cholangitis, and severe obesity (table 1).
Timing of Surgery
The optimal timing of surgery will depend upon the patient’s overall medical condition and underlying diagnosis [14]:
- Acute cholecystitis – Patients with acute cholecystitis, who are surgical candidates, should undergo cholecystectomy as soon as they are fully resuscitated and the most qualified surgeon is available [15,16]. Early cholecystectomy has been associated with improved patient outcomes compared with interval cholecystectomy. (See “Treatment of acute calculous cholecystitis”, section on ‘Timing of cholecystectomy’.)
- Gallstone pancreatitis – Patients with gallstone pancreatitis have a high risk of recurrence within 30 days of their attack and therefore should undergo cholecystectomy during their index hospitalization after their symptoms resolve. In a randomized trial of 266 patients with mild gallstone pancreatitis, same-admission cholecystectomy reduced the rate of readmission or mortality related to gallstones (5 versus 17 percent) without increasing the rate of perioperative complications compared with delayed cholecystectomy [17]. (See “Management of acute pancreatitis”.)
- Obstructive jaundice – A history of pancreatitis or jaundice raises the likelihood of common bile duct (CBD) stones. Patients with isolated obstructive jaundice with or without cholangitis should either have their CBD cleared with urgent endoscopic retrograde cholangiopancreatography (ERCP) preoperatively or with cholangiography and laparoscopic common duct exploration at the time of surgery. If ERCP is successful, the patient should electively be scheduled for cholecystectomy. (See “Endoscopic management of bile duct stones”.)
- Medical comorbidities – Identification of bleeding diatheses and poor cardiopulmonary reserve will help identify patients who may not tolerate pneumoperitoneum or will have higher likelihood for conversion to open operation. In patients with multiple comorbidities or acute medical problems (such as a recent myocardial infarction), a trial of antibiotics with consideration for a percutaneous cholecystostomy tube with delayed laparoscopic cholecystectomy in six to eight weeks may be preferable. (See “Treatment of acute calculous cholecystitis”.)
Preoperative Evaluation
Laboratory testing – Laboratory testing in patients being evaluated for acute cholecystitis typically includes a complete blood count, liver enzymes, amylase, and lipase.
Elevations in the serum total bilirubin and alkaline phosphatase concentrations are not common in uncomplicated cholecystitis, since biliary obstruction is limited to the gallbladder; if present, they should raise concerns about complicating conditions such as cholangitis, choledocholithiasis, or Mirizzi syndrome (a gallstone impacted in the distal cystic duct causing extrinsic compression of the common bile duct). However, mild elevations have been reported even in the absence of these complications and may be due to the passage of small stones, sludge, or pus. (See “Acute calculous cholecystitis: Clinical features and diagnosis”, section on ‘Laboratory findings’.)
For young, otherwise healthy patients with gallstones but no evidence of pericholecystic inflammation or bile duct dilation, additional preoperative laboratory testing is not routinely necessary, unless a new clinical event has occurred, such as significant pain, fever, or jaundice, or the physical examination suggests that an abnormality is present. An electrocardiogram or chest radiograph is obtained as appropriate. (See “Preoperative medical evaluation of the healthy adult patient”, section on ‘Laboratory evaluation’.)
For patients with complicated biliary tract disease, abnormal tests (eg, liver function tests, amylase, lipase) should be repeated to serve as a baseline for postoperative comparison. Coagulation tests are not routinely needed but may be obtained if there is a reason to believe an abnormality may be present.
Imaging — Ultrasonography (US) of the right upper quadrant establishes the diagnosis of gallstones or abnormalities of the gallbladder wall. The US may also demonstrate common bile duct (CBD) dilatation, stones, or evidence of acute inflammation of the gallbladder. Nuclear cholescintigraphy may be useful in cases in which the diagnosis remains uncertain after ultrasonography. (See “Acute calculous cholecystitis: Clinical features and diagnosis”.)
Magnetic resonance cholangiopancreatography (MRCP) may be useful to evaluate the common duct in patients with mild elevations of their transaminases or mild CBD dilatation on US.
Endoscopic retrograde cholangiopancreatography — If a patient has a dilated CBD, CBD stones, or jaundice, consideration should be given to a preoperative endoscopic retrograde cholangiopancreatography (ERCP) with clearing of the stones followed by laparoscopic cholecystectomy. In the absence of frank jaundice or cholangitis, mild abnormalities of liver enzymes and/or bile duct dilation may also be managed effectively with intraoperative evaluation of the CBD (at the time of cholecystectomy), rather than preoperative ERCP. (See “Endoscopic management of bile duct stones”.)
Preparations
Patients should have the procedure described in detail with communication of the possibility of conversion to an open procedure. The patient should be informed about the risks of bile duct injury, bowel injury, vascular injury, and reoperation or need for postoperative endoscopic retrograde cholangiopancreatography (ERCP). (See “Complications of laparoscopic cholecystectomy”.)
Antibiotics — Although society guidelines generally recommend prophylactic antibiotics only for high-risk patients undergoing cholecystectomy [18,19], they are based on old data and inconsistently followed [20]. Some surgeons administer prophylactic antibiotics to low-risk patients as well.
High-risk patients or high-risk procedures — Antibiotic prophylaxis is indicated for high-risk patients undergoing laparoscopic cholecystectomy or any laparoscopic cholecystectomy performed with high-risk procedures. Appropriate choices of antibiotics are summarized in this table (table 2).
High-risk patients are defined by the Scottish Intercollegiate Guideline Network (SIGN) and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) as being at increased risk of wound infection within 30 days of surgery and include patients over 60 years old; patients with diabetes; and patients with acute symptoms of biliary colic within 30 days of surgery, jaundice, acute cholecystitis, or cholangitis [19-21]. Other high-risk groups include patients with immunosuppression and pregnant women. High-risk procedures include intraoperative cholangiography, conversion to laparotomy, insertion of prosthetic devices, and intraoperative bile spillage.
Low-risk patients undergoing low-risk procedures — Practice differs regarding the use of antibiotics in low-risk settings:
- Consistent with society guidelines, some UpToDate contributors believe that patients undergoing elective cholecystectomy who are at low risk for infection do not need prophylactic antibiotics [18,22-26]. Surgical site infection rates following laparoscopic cholecystectomy are generally lower compared with those following open cholecystectomy [27,28]. Infection rates after laparoscopic cholecystectomy have ranged from 0 to 4 percent without antimicrobial prophylaxis and 0 to 7 percent with prophylaxis [27-33].
Multiple meta-analyses have demonstrated no significant differences in the incidence of surgical site infection for low-risk patients receiving or not receiving antimicrobial prophylaxis prior to elective laparoscopic cholecystectomy [22,23,32-35]. These trials have generally included 50 to 175 patients in each arm and have used a single dose of antibiotics administered just prior to surgery.
- However, some surgeons, including all contributors to this topic, routinely administer prophylactic antibiotics prior to all laparoscopic cholecystectomy procedures, including those that are considered low risk. In clinical practice, very few patients will undergo cholecystectomy without one of the risk factors defined above (eg, biliary colic symptoms within 30 days), and several of the high-risk procedures cannot always be anticipated preoperatively (eg, intraoperative cholangiography, bile spillage, conversion to open surgery).
In 2014, a Japanese unblinded randomized trial of 1000 low-risk patients found that the incidence rates of surgical site infection (0.8 versus 2.8 percent) and distant infection (0.2 versus 3.2 percent) were lower for those who received prophylactic antibiotics [29]. Several meta-analyses that included this trial have also found a benefit for prophylactic antibiotics in low-risk patients, although the results were heavily influenced by the Japanese trial because of its size [36-38].
Thromboprophylaxis — Thromboprophylaxis should be administered according to risk. (See “Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients”.)
In a large observational study, systemic thromboprophylaxis was found to increase the incidence of bleeding associated with laparoscopic, but not open, cholecystectomy [39]. Bleeding was defined as that which could not be controlled by standard surgical techniques; led to conversion to an open procedure; or necessitated transfusion, reoperation, or prolonged hospital stay.
Equipment — An angled laparoscope is recommended (typically 30 degrees) to facilitate alternative views of the operative field. Two grasping forceps are needed, one for the assistant and one for the surgeon. Toothed graspers may be helpful for particularly thick-walled, edematous gallbladders.
For the assistant, a ratchet mechanism, which locks the grasper closed, will help alleviate fatigue. A fine curved dissecting forceps can be used to dissect around delicate structures. Scissors are important for transection, and a hook or spatula with monopolar cautery is used for dissection. A clip applier is typically used to seal the cystic duct and artery.
Other tools that should be available include a suction/irrigation device, cholangiogram catheters (4 to 5 French), retrieval bag, endoscopic ligating loops, appropriate trocars (we use a Hasson [blunt-tipped trocar for open insertion], 11 mm, and 2 x 5 mm), endoscopic needle holders, and a Veress needle (if percutaneous technique used).
Standard Procedure
Laparoscopic cholecystectomy is performed under general anesthesia. The generally short duration of the procedure minimizes the need for gastric decompression or placement of a urinary bladder catheter. The following sections describe the technique of a standard laparoscopic cholecystectomy. The technical details such as suture choice presented here reflect the authors’ preferences and are not meant to imply that these are requirements for successful surgical outcomes.
Positioning — The patient is placed in a supine position on the operating room table. During abdominal access and insufflation of the abdomen, the table can remain flat. Thereafter, the patient should be placed in a reverse Trendelenburg position with left side down to allow gravity to aid with exposure of the gallbladder (figure 1).
- In North American positioning, the patient is placed supine on the operating room table. The surgeon stands on the patient’s left and the assistant on the right. The camera operator stands to the surgeon’s left. The primary video monitor should be placed on the right at the level of the shoulder. A second monitor can be placed on the surgeon’s right.
- In the European style, the patient is placed supine with legs abducted, and the surgeon stands between the legs. The camera operator is positioned to the patient’s left and the assistant to the right (figure 1).
Abdominal access — Initial entry into the abdomen is typically obtained at the umbilicus using either an open (Hasson) or closed (Veress needle) technique. Both techniques are discussed in detail elsewhere. (See “Abdominal access techniques used in laparoscopic surgery”, section on ‘Initial port placement’.)
The laparoscope is introduced through the umbilical trocar. Once the abdomen has been inspected, three additional trocars are typically placed under direct vision (figure 2 and figure 3):
- The assistant’s 5 mm trocar is usually placed at the midaxillary line halfway between the costal margin and the anterior superior iliac spine. A grasping forceps is placed to grasp the fundus of the gallbladder and retract it and the liver superiorly.
- A second 5 or 10 mm port, which will accommodate the surgeon’s right-hand instruments, is placed in the high epigastric/subxiphoid region just to the right of the falciform ligament. The size of the trocar depends on the size of the clip applier to be used. This trocar is directed toward the gallbladder neck.
A history of prior abdominal surgery may affect port placement. As an example, in patients who have had a prior coronary artery bypass graft (CABG) utilizing the right gastroepiploic artery, the epigastric port must be placed under direct vision to the right of the falciform ligament as the right gastroepiploic-coronary graft generally runs to the left of the falciform ligament [40]. Thus, preoperative detailed knowledge of the patient’s past surgical history (eg, CABG) is essential to preventing iatrogenic injuries to the graft.
- A third trocar for the surgeon’s left-hand instruments is placed at the right midclavicular line just below the liver edge.
Gallbladder exposure and dissection — The assistant using the ratcheted toothed grasper pushes the fundus of the gallbladder superiorly and laterally to reveal the infundibulum and porta hepatis.
If the gallbladder is distended, it can be difficult to grasp. Aspirating it with a large-bore needle or a sharp-tipped suction device facilitates purchase by the grasper. The grasper (or stitch or ligating loop) can then be used to close the hole to prevent further spillage of content.
Occasionally, adhesions to the duodenum, omentum, or colon from previous surgery or inflammation impair this exposure. The surgeon can take down these adhesions safely by grasping the adhesions at their attachment high on the gallbladder and stripping them down bluntly toward the infundibulum. Minimal electrocautery should be used in order to reduce the risk of thermal injury to the adjacent bowel (figure 1).
Dissection of the hepatocystic triangle — The most important consideration in a cholecystectomy is the clear identification of the cystic artery and duct prior to division.
To this end, a thorough dissection of the hepatocystic triangle, bounded by the gallbladder wall, cystic duct, and common hepatic duct, to obtain the “critical view of safety” is a key step (figure 4) [41] (see ‘Critical view of safety’ below). The surgeon grasps the infundibulum with the left-hand forceps and retracts inferiorly and laterally to open the angle between the cystic duct and common duct. This instrument is used to provide retraction in various angles to give anterior and posterior exposure of the triangle.
Occasionally, a large stone at the gallbladder neck prevents grasping of the infundibulum. This scenario can be managed by dislodging and “milking” the stone back up into the gallbladder body or by placing a stitch into the infundibulum and using that for retraction. The dissection of the junction of the gallbladder and cystic duct begins by the surgeon gently stripping the peritoneum starting high on the gallbladder. Keeping the dissection on a known safe structure (the gallbladder) to develop visualization of the unknown structures is an important principle.
The posterolateral aspect of the gallbladder is the safest area for initial dissection and can be exposed by retracting the infundibulum superior and medial. The surgeon can use minimal cautery or blunt dissection to incise the superficial layer of peritoneum attaching the gallbladder neck to the liver in order to allow further retraction of the infundibulum.
Critical view of safety — Anterior and posterior dissection continues with alternating inferolateral and superomedial retraction of the neck until the gallbladder is dissected away from the liver, creating a “window” crossed by two structures: the cystic duct and artery. This is the “critical view of safety” that should be achieved prior to clipping or dividing any tubular structures (figure 4) [41,42]. (See “Complications of laparoscopic cholecystectomy”.)
There is no need to dissect down to the cystic duct-common bile duct (CBD) junction unless the cystic duct is very short. The cystic artery should be dissected in a similar fashion. Calot’s node, or the cystic duct lymph node, is usually encountered adjacent and anterior to the artery and can be a useful landmark. Electrocautery may be needed for hemostasis before the node can be bluntly swept down (figure 1).
The surgeon should be aware of certain anatomic variations in order to avoid misidentification of structures. A common anomaly is the right hepatic artery looping onto the infundibulum and being mistaken for the cystic artery. A short cystic duct is also seen quite frequently and can drain into the right hepatic duct, the common duct, or a low-lying aberrant right sectoral duct. In the presence of severe, acute, or chronic inflammation, or with a large stone in the neck of the gallbladder, the infundibulum may be “tethered” to the hepatic duct, which may lead the surgeon to misidentify the CBD for the cystic duct.
Division of cystic artery and cystic duct — Once the cystic duct and artery are fully dissected, a clip is placed laterally on the cystic duct adjacent to the gallbladder. The cystic duct is incised distal to the clip, and the side of a closed grasper is used to sweep the bile duct toward the ductotomy to assess cystic duct patency. Then, using a curved dissector, the cystic duct is “milked” retrograde by compressing it toward the ductotomy to identify any stones, bring out any small residual stones, and assess for free flow of bile. Once this is accomplished, two more clips are placed distal to the ductotomy.
Both jaws of the clip should be seen to clearly encompass the duct to avoid inadvertent injuries to structures behind the clips and to ensure complete duct closure. The duct can then be transected with scissors. Alternatives to clipping the cystic duct include tying the duct closed (eg, Endoloop) and the use of advanced tissue sealing devices (eg, Enseal). Monopolar electrocautery should not be used, since the electrical current can be transmitted to the clips and cause delayed necrosis of the stump.
The artery is clipped and divided in a similar fashion. The anterior branch of the cystic artery is commonly mistaken for the main cystic artery; therefore, the tissue behind the clipped artery should be dissected to ensure that there is no posterior branch, which can cause troublesome bleeding during the subsequent removal of the gallbladder. In a study of 100 elective laparoscopic cholecystectomies, 57 contained two or more branches of the cystic artery [43]. The clipped stumps should be inspected for adequacy of closure.
Evaluation for choledocholithiasis — If there is any concern for choledocholithiasis (elevated bilirubin, dilated duct) or uncertain anatomy, the CBD should be imaged intraoperatively. This should occur after the first clip is placed on the cystic duct. Intraoperative cholangiogram (IOC) or laparoscopic ultrasound (LUS) may be performed. Once stones are found and retrieved, a completion cholangiogram should be obtained to verify clearance (image 1).
Intraoperative cholangiogram — Intraoperative cholangiography (IOC) should be accomplished before beginning CBD exploration. The catheter for IOC is placed after careful dissection achieves the critical view of safety (figure 4). The technique of IOC and CBD exploration is discussed elsewhere in detail. (See “Surgical common bile duct exploration”.)
Laparoscopic ultrasound — LUS may alternatively be performed to evaluate the CBD. It requires a certain comfort and skill level. A prospective multicenter study of 209 patients showed that in experienced hands, LUS can be equivalent to an IOC in detecting stones and can be performed almost 50 percent more quickly [44]. On the other hand, IOC is better at detecting intrahepatic anatomy and anatomic anomalies of the biliary tree [44]. A retrospective study of 1381 patients who underwent laparoscopic cholecystectomy at five centers showed that LUS successfully delineated the bile duct anatomy in 98 percent of patients [45].
Dissection of gallbladder from liver bed — The assistant places continual cephalad traction on the gallbladder fundus while the surgeon alternates medial and lateral anteroposterior traction on the infundibulum with the left-hand grasper. This retraction exposes and maintains tension on the plane of tissue attaching the gallbladder to the liver. This tissue is gently divided using a hook or spatula cautery in a sweeping motion. This dissection continues from infundibulum to fundus, and bleeding should be minimal if dissection is performed in the correct plane. Prior to completely detaching the gallbladder, the liver should be inspected for areas of bleeding or bile leakage. The right upper quadrant is irrigated, and then the gallbladder is fully released.
The routine placement of drains is not necessary [46], but, occasionally, persistent minimal bile leakage occurs from the liver bed. This leak may be from a transected duct of Luschka or, more likely, from a superficial duct within the liver that was unroofed during the dissection. If the end of the duct can be grasped, then the duct should be clipped. Otherwise, one may perform intracorporeal suturing of the opening of the duct but, if unsuccessful, leave a closed suction drain to control the leak.
Gallbladder extraction — The umbilical incision is the ideal location for extracting the gallbladder. The umbilical incision has no muscle layers and is easy to extend with minimal pain and cosmetic sequelae. To limit bile contamination of the abdomen and wound, an extraction bag is used when the gallbladder is acutely inflamed and friable or when there was inadvertent perforation of the gallbladder. Any remaining loose stones can be placed in the bag as well. The laparoscope is transferred to the subxiphoid position, and the bag or a large toothed grasper is positioned within the umbilical trocar.
The gallbladder is placed into the bag, or the infundibulum is grasped with the forceps. The trocar is removed, and the gallbladder is withdrawn through this incision under laparoscopic vision. If the gallbladder is very large or contains large stones, the fascial incision may need to be stretched or enlarged. Once the gallbladder is removed, the right upper quadrant can be irrigated if necessary, and the other trocars can be removed under direct vision while allowing escape of CO2. The umbilical fascia is then closed with the stay sutures originally placed.
The specimen can also be retrieved through the subxiphoid port site. Some surgeons feel that the subxiphoid site may be better for specimen extraction as the subxiphoid site has a lower likelihood of hernia formation; however, formal study of this has not been performed [47].
The skin is closed with subcuticular absorbable stitches and with adhesive strips. The access site incisions can be infused with local anesthetic (eg, bupivacaine), which reduces postoperative pain [48]. Some surgeons also instill local anesthetic agents intraperitoneally; however, the benefit is uncertain [49]. Pharmacologic agents to manage postoperative pain are reviewed elsewhere [50]. (See “Approach to the management of acute pain in adults”.)
Alternative Techniques
Alternative techniques for cholecystectomy include needlescopic surgery, single-incision laparoscopic surgery, and robot-assisted laparoscopic surgery. Compared with standard laparoscopic cholecystectomy, these alternative techniques use fewer or smaller trocars with a goal of reducing postoperative pain and improving cosmesis.
In a systematic review and network analysis of 96 randomized trials comparing various cholecystectomy techniques, single-incision cholecystectomy required a longer operative time but no additional clinical benefit compared with standard laparoscopic cholecystectomy [51]. Needlescopic cholecystectomy was associated with the lowest wound infection rate and the shortest length of stay among all minimally invasive cholecystectomy techniques. However, acute cholecystitis, hepatomegaly, thick abdominal wall, and higher body mass index class are likely to exclude needlescopic and single-incision approaches. Robotic cholecystectomy is an investigational technique. As such, standard laparoscopic cholecystectomy remains the routine approach for gallbladder surgery [52].
Needlescopic cholecystectomy — Needlescopic surgery, or mini-laparoscopy, uses instruments that are thinner than the standard instruments (<3 versus 5 to 10 mm). These instruments are either placed directly through the abdominal wall without a trocar or through special low-friction trocars of small diameters (2 to 4 mm). Although needlescopic cholecystectomy requires the same four incisions as standard cholecystectomy, three of the incisions are smaller and therefore less invasive to the patient. The remaining umbilical incision has a standard size of 5 to 10 mm, which permits the use of a standard laparoscope and specimen extraction. About 10 percent of attempted needlescopic cholecystectomies require conversion, most often to standard laparoscopic cholecystectomy rather than open surgery [53]. (See “Instruments and devices used in laparoscopic surgery”, section on ‘Instruments for mini-laparoscopy’.)
In a meta-analysis of 12 randomized trials including 712 patients, needlescopic cholecystectomy resulted in less postoperative pain and better cosmesis than standard laparoscopic cholecystectomy [54]. Operative time and length of hospital stay were similar.
Single-incision laparoscopic cholecystectomy — Laparoscopic single-incision surgery (SIS) uses one rather than multiple skin incisions for trocar placement (picture 1). Through a single skin incision typically made periumbilically, multiple trocars are placed through one or more fascial punctures. (See “Abdominal access techniques used in laparoscopic surgery”, section on ‘Single-incision laparoscopic surgery’.)
SIS has been most widely used in gallbladder surgery and has been extensively studied in comparison with standard laparoscopic cholecystectomy. Overall, SIS offers little benefit over standard laparoscopic surgery [55-72]. A 2017 meta-analysis of 37 trials comparing SIS with conventional laparoscopic cholecystectomy showed that SIS is associated with better cosmesis, body image, and wound satisfaction and less postoperative pain but a slightly longer operative time and a higher conversion rate (mostly to conventional laparoscopy). Additionally, the risk of incisional hernia is four times higher after SIS than after conventional LC [73].
Robotic cholecystectomy — Robot-assisted cholecystectomy has also been performed (movie 1). Compared with conventional laparoscopic cholecystectomy, robotic cholecystectomy has not been found to be more effective or safer than for benign gallbladder diseases, but it incurs longer operative time and higher cost [74-77]. The use of robotic-assisted extended cholecystectomy for gallbladder cancer is currently being evaluated [78,79].
Special Considerations
Cirrhosis — Cirrhotic patients with portal hypertension pose a particular challenge to the surgeon [80,81]. They are at higher risk for any surgical procedure, and preoperative preparation is critical for good outcomes. These patients should have their liver function optimized prior to an elective cholecystectomy. Some may need replacement of clotting factors to minimize intraoperative bleeding. (See “Assessing surgical risk in patients with liver disease”.)
Care should be taken when placing trocars to avoid the “caput medusa” of large collateral vessels in the abdominal wall. The cirrhotic liver itself is usually quite hard and easily injured just with retraction. Bleeding from a cirrhotic liver is difficult to control, so remaining in the correct plane during dissection of the gallbladder from the liver is particularly important.
Various hemostatic agents and energy sources (the argon cautery device can be quite useful) need to be available in case bleeding develops [82]. Particular care should be taken in making watertight closures for all incisions to minimize perioperative ascitic leak [83].
In a study of 349 cirrhotic patients undergoing cholecystectomy (59 percent laparoscopic), the morbidity and mortality rates were 18.7 and 3.8 percent, respectively. The Model for End-Stage Liver Disease (MELD) score was an independent factor of morbidity and mortality, while the laparoscopic approach had a protective effect on morbidity. A nomogram can be used to predict outcomes [84].
Pregnancy — There is a strong association between pregnancy and gallstones. In the past, elective laparoscopic cholecystectomy for symptomatic gallstones was deferred as much as possible until after pregnancy. For patients with severe biliary colic, however, waiting until after pregnancy can lead to repeated hospitalizations and complications [85]. Laparoscopic gallbladder surgery has been performed safely during pregnancy by experienced surgeons [86]. In the guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy (2007), the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) organization stated that laparoscopic cholecystectomy can be performed safely during any trimester of pregnancy [87]. We concur with that statement.
When laparoscopic surgery is performed in pregnant patients, the trocars need to be placed higher in the abdomen due to the enlarged uterus. The CO2 insufflation should be kept at the lowest possible pressure while maintaining an adequate working space. If common bile duct (CBD) imaging is necessary, laparoscopic ultrasound should be used in place of intraoperative cholangiogram to limit radiation exposure. Preoperative obstetric consultation and perioperative fetal monitoring are advisable [88]. Details of proper positioning for surgery and management of pregnant patients undergoing surgery are discussed elsewhere. (See “Anesthesia for nonobstetric surgery during pregnancy” and “Laparoscopic surgery in pregnancy”.)
Obesity — Because patients with obesity have a thick abdominal wall, trocar placement is particularly important. The thickness of the wall inhibits the mobility of the trocars, so they should be placed at the angle most likely to be used during the cholecystectomy. Longer trocars may be needed to traverse the abdominal wall in order to avoid trocar displacement and subsequent insufflation within the abdominal wall and subcutaneous emphysema. Longer instruments may be required to reach the gallbladder, and the initial umbilical trocar may need to be placed at a supraumbilical position. The surgeon should not hesitate to place additional trocars if needed. Although laparoscopy may be more challenging in patients with severe obesity, it may offer advantages specific to these patients such as decreased wound infection, deep vein thrombosis (DVT), and incisional hernias, which may make laparoscopy the preferred approach [89,90].
Gangrenous cholecystitis — Laparoscopic cholecystectomy can be done safely in the setting of acute or gangrenous cholecystitis and should be done as soon as possible to fall within the “golden period” within 72 hours when edema is the primary manifestation of the inflammation. If the patient presents in a delayed fashion (>72 hours from onset of symptoms), the surgery can be performed if there are no contraindications to an open procedure, as conversion is a significant risk. In the face of acute cholecystitis with multiple comorbidities, it may be preferable to treat with intravenous antibiotics and possibly percutaneous drainage, with subsequent laparoscopic cholecystectomy six to eight weeks later. (See “Treatment of acute calculous cholecystitis”.)
Different techniques may be needed when a gangrenous gallbladder or dense inflammation is encountered. A “top-down” approach to dissection of the gallbladder as in an open procedure may be necessary to appreciate the anatomy [91,92]. The surgeon may perform subtotal cholecystectomy by transecting the infundibulum as close to the cystic duct as possible and extracting all stones. The gallbladder neck is then sewn closed, if possible, and a drain is placed in the gallbladder bed. This transection of an edematous, friable wall may be facilitated by using the ultrasonic shears. In a gallbladder densely adherent to the liver where the plane between the two is obliterated and/or in the presence of portal hypertension, it may be preferable to leave the back wall of the gallbladder intact and fully cauterize its mucosa [93]. Blunt dissection with a suction irrigator or laparoscopic peanut is particularly useful in defining anatomy around a grossly inflamed duct. An active suction drain should be left beneath the liver if there is any question regarding the integrity of the cystic duct closure or any suspicion of bile leakage from the gallbladder bed. We do not place a drain to monitor for bleeding.
Commonly referred to as a “difficult gallbladder” is a scenario in which a cholecystectomy incurs an increased surgical risk compared with standard cholecystectomy [94]. Cholecystectomy can be made difficult by processes that either obscure normal biliary anatomy (eg, acute or chronic inflammation) or operative exposure (eg, obesity or prior upper abdominal surgery). Strategies to manage a difficult gallbladder are discussed in detail elsewhere. (See “Managing the difficult gallbladder”.)
Large cystic duct — Occasionally the cystic duct is quite enlarged and inflamed and standard clips are inadequate to seal the duct. In these instances, preformed suture loops may be helpful in completely closing the duct. Some surgeons may suture ligate the cystic duct stump using intracorporeal suturing, while others use extracorporeal knot tying in order to control the duct before transecting it. Rarely, an endoscopic stapler is used to transect an unusually large cystic duct after assuring that the structure is not, in fact, the common bile duct.
Intraoperative Complications
Major complications, including vascular injury, bowel perforation, mesenteric injury, and bile duct injuries, often require immediate laparotomy. A laparoscopic operation should be converted to an open procedure if the surgeon encounters a situation demanding manual palpation and direct vision for correction. Surgeons should convert to open operations without hesitation if the need arises. Open cholecystectomy is discussed in detail elsewhere. (See “Open cholecystectomy”.)
- Conversion to an open operation is indicated for:
- Hemorrhage
- Unusual or confusing anatomy
- Failure to progress laparoscopically in a timely fashion
- Bowel perforation or major injury to the bile ducts
- Potentially resectable gallbladder cancer
- Common bile duct stones that cannot be removed laparoscopically or endoscopically (due to Billroth II anatomy, previously failed endoscopic retrograde cholangiopancreatography [ERCP], or lack of an experienced endoscopist)
Complications of laparoscopic cholecystectomy, particularly common bile duct injury, are discussed in detail separately but will be summarized here. (See “Complications of laparoscopic cholecystectomy” and “Repair of common bile duct injuries”.)
- Gallbladder perforation – During the dissection of the gallbladder, the surgeon may enter the gallbladder inadvertently, causing spillage of bile and/or stones. The hole in the gallbladder can be closed by incorporating it within the grasping forceps or may be sutured closed to prevent further spillage. The bile should be suctioned and irrigated. Bile spillage, when not accompanied by stone spillage and promptly evacuated, has not been shown to increase postoperative infections [95].
On the contrary, gallstones, particularly pigment stones, which harbor bacteria, can increase the risk of postoperative infection if left in the abdomen or port site [96-99]. Thus, any spilled gallstones should be extracted if at all possible. Large stone graspers are helpful in performing this task.
- Vascular injury – If a trocar impales a major blood vessel, the trocar should not be removed but allowed to tamponade the vessel while an immediate laparotomy is performed. Another site of hemorrhage is from lacerated abdominal wall vessels; therefore, trocars should be visualized with the laparoscope when removed. Bleeding from these sites can usually be controlled with cautery, Foley catheter balloon tamponade, or a figure-of-eight stitch placed directly or with a suture passer.
- Bowel injury – Bowel injuries should be marked and closely observed during and at the end of the case. If leakage occurs, the injury can be repaired laparoscopically or in an open fashion through extension of the umbilical incision. Then the procedure can proceed laparoscopically.
- Bile duct injuries – Major bile duct injuries should be immediately repaired if recognized. There is interest in using fluorescent imaging with indocyanine green to define biliary anatomy and prevent bile duct injuries. There is not enough evidence to recommend this, but the technique appears promising [100,101].
Some bile duct injuries may be unrecognized at the time of surgery and present in a delayed fashion. These should all be referred to an experienced biliary surgeon since the greatest chance for successful repair is at the first operation. If the surgeon is at another facility, the patient should be externally drained prior to transfer. (See “Repair of common bile duct injuries”.)
Routine Postoperative Care
After an uncomplicated elective laparoscopic cholecystectomy, patients can drink clear liquids once awake from anesthesia, and their diet can be advanced as tolerated.
Most otherwise healthy, reliable patients with good home support can leave the hospital within six hours after surgery. Cochrane reviews have found no significant differences for important clinical outcomes for patients discharged the same day versus admitted overnight following laparoscopic cholecystectomy [102,103]. A retrospective review of the American College of Surgeon’s National Surgical Quality Improvement Program (NSQIP) database, which included 15,248 patients older than 65 years of age who underwent elective laparoscopic cholecystectomy, identified congestive heart failure, American Society of Anesthesiologists class 4, bleeding disorder, and renal failure requiring dialysis as significant independent predictors of inpatient admission and mortality [104].
The patient should have no activity restriction unless the umbilical incision was particularly large. Then, limited heavy lifting for a few weeks is advisable. Most patients are able to return to work within one week. Patients follow up in clinic two to four weeks after their operation.
Most patients have some abdominal pain that resolves within two to three days after surgery and can be managed with analgesics. Occasionally, patients have referred shoulder and neck pain from the CO2 insufflation causing diaphragmatic irritation.
Postoperative Complications
Serious complications that occur with laparoscopic cholecystectomy, including bile duct injury, bile leaks, bleeding, and bowel injury, result in part from patient selection, surgical inexperience, and the technical constraints that are inherent to the minimally invasive approach. These are discussed in detail elsewhere. (See “Complications of laparoscopic cholecystectomy”.)
Other adverse outcomes, such as retained common bile duct (CBD) stones (incidence of around 10 percent), postcholecystectomy syndromes, and misdiagnoses (sphincter of Oddi dysfunction), occur with the same frequency with both laparoscopic and open cholecystectomy. (See “Choledocholithiasis: Clinical manifestations, diagnosis, and management”.)
Postcholecystectomy syndrome — Postcholecystectomy syndrome (PCS) is a complex of heterogeneous symptoms, including persistent abdominal pain and dyspepsia, that recur and persist after cholecystectomy [105,106]. In a prospective cohort study, only 60 percent of patients reported complete relief of abdominal pain at 12 weeks after cholecystectomy for uncomplicated symptomatic cholelithiasis [107].
In a trial of over 1000 patients with abdominal pain and ultrasound-proven gallstones or sludge, patients were randomly assigned to either usual care (control group) or laparoscopic cholecystectomy only if they fulfilled prespecified criteria based on the Rome III criteria of biliary colic (experimental group) [108]. Fewer patients in the experimental group received surgery (68 versus 75 percent). At 12 months, however, 40 and 44 percent of the control and experimental groups and 37 and 36 percent of those who underwent cholecystectomy in the two groups still had abdominal pain. A post hoc cost-effectiveness analysis reported that after 12 months, 56.2 percent of patients were pain free in the experimental group versus 59.8 percent after usual care. The restrictive strategy reduced the cholecystectomy rate by 7 percent and reduced surgical costs by €160 per patient but resulted in fewer pain-free patients [109].
This trial showed suboptimal pain reduction regardless of whether patients were preselected for cholecystectomy. All can agree that a very accurate history and physical examination, in conjunction with good diagnostic testing, is critical for selecting the appropriate patients for cholecystectomy. Clearly, as gallstones and abdominal pain are both relatively common, there is a need for diagnostic tests that will allow a more accurate identification of those patients with gallstones who will benefit from cholecystectomy. Until such tests become available, surgeons need to warn patients that cholecystectomy may not relieve their pain.
PCS is defined as “early” if it occurs in the postoperative period and “late” if it occurs months or years after surgery. The symptoms of pain and dyspepsia referred to as PCS can be caused by a wide spectrum of conditions, both biliary and extrabiliary. About one-half of the patients with PCS are found to have biliary, pancreatic, or gastrointestinal disorders, while the remaining patients have extraintestinal disease [106].
- Biliary causes of PCS include:
- Early PCS can be due to biliary injury, retained cystic duct, or CBD stones.
- Late PCS can be due to recurrent CBD stones, bile duct strictures, an inflamed cystic duct or gallbladder remnant, papillary stenosis, or biliary dyskinesia. Biliary dyskinesia refers to motor forms of sphincter of Oddi dysfunction. Sphincter of Oddi dysfunction can be evaluated with sphincter of Oddi manometry, which is discussed in detail elsewhere.
- Extrabiliary causes of PCS include:
- Gastrointestinal causes such as irritable bowel syndrome, pancreatitis, pancreatic tumors, pancreas divisum, hepatitis, peptic ulcer disease, mesenteric ischemia, diverticulitis, or esophageal diseases.
- Extraintestinal causes such as intercostal neuritis, wound neuroma, coronary artery disease, or psychosomatic disorders.
Treatment for PCS is tailored to the specific cause of the symptoms. Diagnosis of the underlying problem causing PCS usually requires imaging to look for retained or recurrent stones or identify a bile duct leak, stricture, or transection. This can be accomplished in most cases with ultrasound and/or computed tomography (CT) scanning followed by direct cholangiography or magnetic resonance cholangiopancreatography (MRCP). MRCP provides a noninvasive alternative to direct cholangiography for evaluation of the biliary tract. The approach to the diagnosis of choledocholithiasis or biliary injury is discussed elsewhere. (See “Choledocholithiasis: Clinical manifestations, diagnosis, and management”, section on ‘Subsequent evaluation and management’ and “Complications of laparoscopic cholecystectomy”, section on ‘Biliary injury’.)
Society Guideline Links
Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See “Society guideline links: Gallbladder surgery” and “Society guideline links: Laparoscopic and robotic surgery”.)
Information For Patients
UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)
- Basics topic (see “Patient education: Choosing surgery to treat gallstones (The Basics)”)
Summary and Recommendations
- Indications – Laparoscopic cholecystectomy is considered the “gold standard” for the surgical treatment of gallstone disease. It has the same indications as for open cholecystectomy. The optimal timing of surgery will depend on the patient’s overall medical condition and underlying diagnosis. (See ‘Introduction’ above and ‘Indications’ above and ‘Timing of surgery’ above.)
- Preoperative evaluation
- Liver function tests (LFTs) should be obtained preoperatively. Elevation in the serum total bilirubin and alkaline phosphatase concentrations should raise concerns about complicating conditions. (See ‘Preoperative evaluation’ above.)
- Ultrasonography (US) of the right upper quadrant establishes the diagnosis of gallstones, abnormalities of the gallbladder wall, common bile duct (CBD) dilatation, stones, or evidence of acute inflammation of the gallbladder. (See ‘Preoperative evaluation’ above.)
- If a patient has a dilated CBD, CBD stones, or jaundice, preoperative endoscopic retrograde cholangiopancreatography (ERCP) or intraoperative cholangiography and possible CBD exploration should be performed. (See ‘Preoperative evaluation’ above.)
- Preoperative discussion with the patient should include the possibility of conversion to an open procedure. The patient should be informed about the risks of bile duct injury, bowel injury, vascular injury, and reoperation or need for postoperative ERCP. (See ‘Preoperative evaluation’ above.)
- For high-risk patients undergoing laparoscopic cholecystectomy or all patients undergoing laparoscopic cholecystectomy with a high-risk procedure defined above, we suggest prophylactic antibiotics (Grade 2C). Appropriate agents are in this table (table 2). (See ‘High-risk patients or high-risk procedures’ above.)
For low-risk patients undergoing laparoscopic cholecystectomy without a high-risk procedure, some UpToDate contributors do, while other UpToDate contributors do not, administer prophylactic antibiotics. There are data to support either practice. (See ‘Low-risk patients undergoing low-risk procedures’ above.)
- Standard procedure – The most important consideration in a cholecystectomy is the clear identification of the cystic artery and duct prior to division. The “critical view of safety” should be achieved prior to clipping or dividing any tubular structures. (See ‘Standard procedure’ above.)
- Alternative techniques – Alternative minimally invasive techniques of laparoscopic cholecystectomy (eg, needlescopic, single-incision laparoscopic) can be used (where available) for select patients who desire minimal pain and optimal cosmesis. (See ‘Alternative techniques’ above.)
- Conversion to open surgery – A laparoscopic operation should be converted to an open procedure if the surgeon encounters a situation demanding manual palpation and direct vision for correction. Surgeons should convert to open operations without hesitation if the need arises. (See ‘Intraoperative complications’ above.)
References
- https://www.uptodate.com/contents/laparoscopic-cholecystectomy
- Csikesz NG, Singla A, Murphy MM, et al. Surgeon volume metrics in laparoscopic cholecystectomy. Dig Dis Sci 2010; 55:2398.
- Soper NJ, Stockmann PT, Dunnegan DL, Ashley SW. Laparoscopic cholecystectomy. The new ‘gold standard’? Arch Surg 1992; 127:917.
- Schirmer BD, Edge SB, Dix J, et al. Laparoscopic cholecystectomy. Treatment of choice for symptomatic cholelithiasis. Ann Surg 1991; 213:665.
- Wiesen SM, Unger SW, Barkin JS, et al. Laparoscopic cholecystectomy: the procedure of choice for acute cholecystitis. Am J Gastroenterol 1993; 88:334.
- Wilson RG, Macintyre IM, Nixon SJ, et al. Laparoscopic cholecystectomy as a safe and effective treatment for severe acute cholecystitis. BMJ 1992; 305:394.
- Rattner DW, Ferguson C, Warshaw AL. Factors associated with successful laparoscopic cholecystectomy for acute cholecystitis. Ann Surg 1993; 217:233.
- Johansson M, Thune A, Nelvin L, et al. Randomized clinical trial of open versus laparoscopic cholecystectomy in the treatment of acute cholecystitis. Br J Surg 2005; 92:44.
- Yamashita Y, Takada T, Kawarada Y, et al. Surgical treatment of patients with acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007; 14:91.
- Vollmer CM Jr, Callery MP. Biliary injury following laparoscopic cholecystectomy: why still a problem? Gastroenterology 2007; 133:1039.
- Khan MH, Howard TJ, Fogel EL, et al. Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center. Gastrointest Endosc 2007; 65:247.
- Keus F, Broeders IA, van Laarhoven CJ. Gallstone disease: Surgical aspects of symptomatic cholecystolithiasis and acute cholecystitis. Best Pract Res Clin Gastroenterol 2006; 20:1031.
- Sinha R, Gurwara AK, Gupta SC. Laparoscopic cholecystectomy under spinal anesthesia: a study of 3492 patients. J Laparoendosc Adv Surg Tech A 2009; 19:323.
- Steinert R, Nestler G, Sagynaliev E, et al. Laparoscopic cholecystectomy and gallbladder cancer. J Surg Oncol 2006; 93:682.
- Lo CM, Liu CL, Fan ST, et al. Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg 1998; 227:461.
- Gurusamy K, Samraj K, Gluud C, et al. Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 2010; 97:141.
- Gutt CN, Encke J, Köninger J, et al. Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg 2013; 258:385.
- da Costa DW, Bouwense SA, Schepers NJ, et al. Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. Lancet 2015; 386:1261.
- Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013; 14:73.
- Overby DW, Apelgren KN, Richardson W, et al. SAGES guidelines for the clinical application of laparoscopic biliary tract surgery. Surg Endosc 2010; 24:2368.
- Graham HE, Vasireddy A, Nehra D. A national audit of antibiotic prophylaxis in elective laparoscopic cholecystectomy. Ann R Coll Surg Engl 2014; 96:377.
- Scottish Intercollegiate Guidelines Network (SIGN). SIGN 104: Antibiotic prophylaxis in surgery. A national clinical guideline. July 2008, updated April 2014.
- Sanabria A, Dominguez LC, Valdivieso E, Gomez G. Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy. Cochrane Database Syst Rev 2010; :CD005265.
- Yan RC, Shen SQ, Chen ZB, et al. The role of prophylactic antibiotics in laparoscopic cholecystectomy in preventing postoperative infection: a meta-analysis. J Laparoendosc Adv Surg Tech A 2011; 21:301.
- Procter LD, Davenport DL, Bernard AC, Zwischenberger JB. General surgical operative duration is associated with increased risk-adjusted infectious complication rates and length of hospital stay. J Am Coll Surg 2010; 210:60.
- Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.
- Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.
- Varela JE, Wilson SE, Nguyen NT. Laparoscopic surgery significantly reduces surgical-site infections compared with open surgery. Surg Endosc 2010; 24:270.
- Siddiqui K, Khan AF. Comparison of frequency of wound infection: open vs laparoscopic cholecystectomy. J Ayub Med Coll Abbottabad 2006; 18:21.
- Matsui Y, Satoi S, Kaibori M, et al. Antibiotic prophylaxis in laparoscopic cholecystectomy: a randomized controlled trial. PLoS One 2014; 9:e106702.
- Chang WT, Lee KT, Chuang SC, et al. The impact of prophylactic antibiotics on postoperative infection complication in elective laparoscopic cholecystectomy: a prospective randomized study. Am J Surg 2006; 191:721.
- Koc M, Zulfikaroglu B, Kece C, Ozalp N. A prospective randomized study of prophylactic antibiotics in elective laparoscopic cholecystectomy. Surg Endosc 2003; 17:1716.
- Zhou H, Zhang J, Wang Q, Hu Z. Meta-analysis: Antibiotic prophylaxis in elective laparoscopic cholecystectomy. Aliment Pharmacol Ther 2009; 29:1086.
- Choudhary A, Bechtold ML, Puli SR, et al. Role of prophylactic antibiotics in laparoscopic cholecystectomy: a meta-analysis. J Gastrointest Surg 2008; 12:1847.
- Pasquali S, Boal M, Griffiths EA, et al. Meta-analysis of perioperative antibiotics in patients undergoing laparoscopic cholecystectomy. Br J Surg 2016; 103:27.
- Gomez-Ospina JC, Zapata-Copete JA, Bejarano M, García-Perdomo HA. Antibiotic Prophylaxis in Elective Laparoscopic Cholecystectomy: a Systematic Review and Network Meta-Analysis. J Gastrointest Surg 2018; 22:1193.
- Yang J, Gong S, Lu T, et al. Reduction of risk of infection during elective laparoscopic cholecystectomy using prophylactic antibiotics: a systematic review and meta-analysis. Surg Endosc 2021; 35:6397.
- Matsui Y, Satoi S, Hirooka S, et al. Reappraisal of previously reported meta-analyses on antibiotic prophylaxis for low-risk laparoscopic cholecystectomy: an overview of systematic reviews. BMJ Open 2018; 8:e016666.
- Liang B, Dai M, Zou Z. Safety and efficacy of antibiotic prophylaxis in patients undergoing elective laparoscopic cholecystectomy: A systematic review and meta-analysis. J Gastroenterol Hepatol 2016; 31:921.
- Persson G, Strömberg J, Svennblad B, Sandblom G. Risk of bleeding associated with use of systemic thromboembolic prophylaxis during laparoscopic cholecystectomy. Br J Surg 2012; 99:979.
- Matsui Y, Hirooka S, Ryota H, et al. Safety of laparoscopic cholecystectomy after coronary artery bypass with the right gastroepiploic artery. Surgery 2016; 160:252.
- Avgerinos C, Kelgiorgi D, Touloumis Z, et al. One thousand laparoscopic cholecystectomies in a single surgical unit using the “critical view of safety” technique. J Gastrointest Surg 2009; 13:498.
- Strasberg SM, Hertl M, Soper NJ. An analysis of the problem of biliary injury during laparoscopic cholecystectomy. J Am Coll Surg 1995; 180:101.
- Ostapenko A, Kleiner D. Challenging Orthodoxy: beyond the Critical View of Safety. J Gastrointest Surg 2023; 27:89.
- Stiegmann GV, Soper NJ, Filipi CJ, et al. Laparoscopic ultrasonography as compared with static or dynamic cholangiography at laparoscopic cholecystectomy. A prospective multicenter trial. Surg Endosc 1995; 9:1269.
- Machi J, Johnson JO, Deziel DJ, et al. The routine use of laparoscopic ultrasound decreases bile duct injury: a multicenter study. Surg Endosc 2009; 23:384.
- Gurusamy KS, Koti R, Davidson BR. Routine abdominal drainage versus no abdominal drainage for uncomplicated laparoscopic cholecystectomy. Cochrane Database Syst Rev 2013; :CD006004.
- Tonouchi H, Ohmori Y, Kobayashi M, Kusunoki M. Trocar site hernia. Arch Surg 2004; 139:1248.
- Loizides S, Gurusamy KS, Nagendran M, et al. Wound infiltration with local anaesthetic agents for laparoscopic cholecystectomy. Cochrane Database Syst Rev 2014; :CD007049.
- Rutherford D, Massie EM, Worsley C, Wilson MS. Intraperitoneal local anaesthetic instillation versus no intraperitoneal local anaesthetic instillation for laparoscopic cholecystectomy. Cochrane Database Syst Rev 2021; 10:CD007337.
- Gurusamy KS, Vaughan J, Toon CD, Davidson BR. Pharmacological interventions for prevention or treatment of postoperative pain in people undergoing laparoscopic cholecystectomy. Cochrane Database Syst Rev 2014; :CD008261.
- Zhao JJ, Syn NL, Chong C, et al. Comparative outcomes of needlescopic, single-incision laparoscopic, standard laparoscopic, mini-laparotomy, and open cholecystectomy: A systematic review and network meta-analysis of 96 randomized controlled trials with 11,083 patients. Surgery 2021; 170:994.
- Jung JJ, Gee DW. Standard laparoscopy remains the routine approach to cholecystectomy. Surgery 2021; 170:1004.
- Thakur V, Schlachta CM, Jayaraman S. Minilaparoscopic versus conventional laparoscopic cholecystectomy a systematic review and meta-analysis. Ann Surg 2011; 253:244.
- Hosono S, Osaka H. Minilaparoscopic versus conventional laparoscopic cholecystectomy: a meta-analysis of randomized controlled trials. J Laparoendosc Adv Surg Tech A 2007; 17:191.
- Marks JM, Phillips MS, Tacchino R, et al. Single-incision laparoscopic cholecystectomy is associated with improved cosmesis scoring at the cost of significantly higher hernia rates: 1-year results of a prospective randomized, multicenter, single-blinded trial of traditional multiport laparoscopic cholecystectomy vs single-incision laparoscopic cholecystectomy. J Am Coll Surg 2013; 216:1037.
- Pan MX, Jiang ZS, Cheng Y, et al. Single-incision vs three-port laparoscopic cholecystectomy: prospective randomized study. World J Gastroenterol 2013; 19:394.
- Hodgett SE, Hernandez JM, Morton CA, et al. Laparoendoscopic single site (LESS) cholecystectomy. J Gastrointest Surg 2009; 13:188.
- Marks J, Tacchino R, Roberts K, et al. Prospective randomized controlled trial of traditional laparoscopic cholecystectomy versus single-incision laparoscopic cholecystectomy: report of preliminary data. Am J Surg 2011; 201:369.
- Joseph M, Phillips MR, Farrell TM, Rupp CC. Single incision laparoscopic cholecystectomy is associated with a higher bile duct injury rate: a review and a word of caution. Ann Surg 2012; 256:1.
- Pietrabissa A, Sbrana F, Morelli L, et al. Overcoming the challenges of single-incision cholecystectomy with robotic single-site technology. Arch Surg 2012; 147:709.
- Saad S, Strassel V, Sauerland S. Randomized clinical trial of single-port, minilaparoscopic and conventional laparoscopic cholecystectomy. Br J Surg 2013; 100:339.
- Phillips MS, Marks JM, Roberts K, et al. Intermediate results of a prospective randomized controlled trial of traditional four-port laparoscopic cholecystectomy versus single-incision laparoscopic cholecystectomy. Surg Endosc 2012; 26:1296.
- Philipp SR, Miedema BW, Thaler K. Single-incision laparoscopic cholecystectomy using conventional instruments: early experience in comparison with the gold standard. J Am Coll Surg 2009; 209:632.
- Ponsky TA. Single port laparoscopic cholecystectomy in adults and children: tools and techniques. J Am Coll Surg 2009; 209:e1.
- Lirici MM, Califano AD, Angelini P, Corcione F. Laparo-endoscopic single site cholecystectomy versus standard laparoscopic cholecystectomy: results of a pilot randomized trial. Am J Surg 2011; 202:45.
- Tsimoyiannis EC, Tsimogiannis KE, Pappas-Gogos G, et al. Different pain scores in single transumbilical incision laparoscopic cholecystectomy versus classic laparoscopic cholecystectomy: a randomized controlled trial. Surg Endosc 2010; 24:1842.
- Love KM, Durham CA, Meara MP, et al. Single-incision laparoscopic cholecystectomy: a cost comparison. Surg Endosc 2011; 25:1553.
- Bucher P, Pugin F, Buchs NC, et al. Randomized clinical trial of laparoendoscopic single-site versus conventional laparoscopic cholecystectomy. Br J Surg 2011; 98:1695.
- Ma J, Cassera MA, Spaun GO, et al. Randomized controlled trial comparing single-port laparoscopic cholecystectomy and four-port laparoscopic cholecystectomy. Ann Surg 2011; 254:22.
- Sajid MS, Ladwa N, Kalra L, et al. Single-incision laparoscopic cholecystectomy versus conventional laparoscopic cholecystectomy: meta-analysis and systematic review of randomized controlled trials. World J Surg 2012; 36:2644.
- Leung D, Yetasook AK, Carbray J, et al. Single-incision surgery has higher cost with equivalent pain and quality-of-life scores compared with multiple-incision laparoscopic cholecystectomy: a prospective randomized blinded comparison. J Am Coll Surg 2012; 215:702.
- Chuang SH, Lin CS. Single-incision laparoscopic surgery for biliary tract disease. World J Gastroenterol 2016; 22:736.
- Haueter R, Schütz T, Raptis DA, et al. Meta-analysis of single-port versus conventional laparoscopic cholecystectomy comparing body image and cosmesis. Br J Surg 2017; 104:1141.
- Han C, Shan X, Yao L, et al. Robotic-assisted versus laparoscopic cholecystectomy for benign gallbladder diseases: a systematic review and meta-analysis. Surg Endosc 2018; 32:4377.
- Huang Y, Chua TC, Maddern GJ, Samra JS. Robotic cholecystectomy versus conventional laparoscopic cholecystectomy: A meta-analysis. Surgery 2017; 161:628.
- Khorgami Z, Li WT, Jackson TN, et al. The cost of robotics: an analysis of the added costs of robotic-assisted versus laparoscopic surgery using the National Inpatient Sample. Surg Endosc 2019; 33:2217.
- Pokala B, Flores L, Armijo PR, et al. Robot-assisted cholecystectomy is a safe but costly approach: A national database review. Am J Surg 2019; 218:1213.
- Byun Y, Choi YJ, Kang JS, et al. Robotic extended cholecystectomy in gallbladder cancer. Surg Endosc 2020; 34:3256.
- Goel M, Khobragade K, Patkar S, et al. Robotic surgery for gallbladder cancer: Operative technique and early outcomes. J Surg Oncol 2019; 119:958.
- Hamad MA, Thabet M, Badawy A, et al. Laparoscopic versus open cholecystectomy in patients with liver cirrhosis: a prospective, randomized study. J Laparoendosc Adv Surg Tech A 2010; 20:405.
- Quillin RC 3rd, Burns JM, Pineda JA, et al. Laparoscopic cholecystectomy in the cirrhotic patient: predictors of outcome. Surgery 2013; 153:634.
- Bessa SS, Abdel-Razek AH, Sharaan MA, et al. Laparoscopic cholecystectomy in cirrhotics: a prospective randomized study comparing the conventional diathermy and the harmonic scalpel for gallbladder dissection. J Laparoendosc Adv Surg Tech A 2011; 21:1.
- Poggio JL, Rowland CM, Gores GJ, et al. A comparison of laparoscopic and open cholecystectomy in patients with compensated cirrhosis and symptomatic gallstone disease. Surgery 2000; 127:405.
- Shahait A, Mesquita-Neto JWB, Hasnain MR, et al. Outcomes of cholecystectomy in US veterans with cirrhosis: Predicting outcomes using nomogram. Am J Surg 2021; 221:538.
- Jorge AM, Keswani RN, Veerappan A, et al. Non-operative management of symptomatic cholelithiasis in pregnancy is associated with frequent hospitalizations. J Gastrointest Surg 2015; 19:598.
- Soper NJ, Hunter JG, Petrie RH. Laparoscopic cholecystectomy during pregnancy. Surg Endosc 1992; 6:115.
- Guidelines Committee of the Society of American Gastrointestinal and Endoscopic Surgeons, Yumi H. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee. Surg Endosc 2008; 22:849.
- Guidelines for laparoscopic surgery during pregnancy. Surg Endosc 1998; 12:189.
- Curet MJ. Special problems in laparoscopic surgery. Previous abdominal surgery, obesity, and pregnancy. Surg Clin North Am 2000; 80:1093.
- Simopoulos C, Botaitis S, Karayiannakis AJ, et al. The contribution of acute cholecystitis, obesity, and previous abdominal surgery on the outcome of laparoscopic cholecystectomy. Am Surg 2007; 73:371.
- Mahmud S, Masaud M, Canna K, Nassar AH. Fundus-first laparoscopic cholecystectomy. Surg Endosc 2002; 16:581.
- Philips JA, Lawes DA, Cook AJ, et al. The use of laparoscopic subtotal cholecystectomy for complicated cholelithiasis. Surg Endosc 2008; 22:1697.
- Beldi G, Glättli A. Laparoscopic subtotal cholecystectomy for severe cholecystitis. Surg Endosc 2003; 17:1437.
- Elshaer M, Gravante G, Thomas K, et al. Subtotal cholecystectomy for “difficult gallbladders”: systematic review and meta-analysis. JAMA Surg 2015; 150:159.
- Jones DB, Dunnegan DL, Soper NJ. The influence of intraoperative gallbladder perforation on long-term outcome after laparoscopic cholecystectomy. Surg Endosc 1995; 9:977.
- Deziel DJ, Millikan KW, Economou SG, et al. Complications of laparoscopic cholecystectomy: a national survey of 4,292 hospitals and an analysis of 77,604 cases. Am J Surg 1993; 165:9.
- Carlin CB, Kent RB Jr, Laws HL. Spilled gallstones–complications of abdominal-wall abscesses. Case report and review of the literature. Surg Endosc 1995; 9:341.
- Horton M, Florence MG. Unusual abscess patterns following dropped gallstones during laparoscopic cholecystectomy. Am J Surg 1998; 175:375.
- Zamir G, Lyass S, Pertsemlidis D, Katz B. The fate of the dropped gallstones during laparoscopic cholecystectomy. Surg Endosc 1999; 13:68.
- Ishizawa T, Bandai Y, Kokudo N. Fluorescent cholangiography using indocyanine green for laparoscopic cholecystectomy: an initial experience. Arch Surg 2009; 144:381.
- Pertsemlidis D, Barzilai A, Persemlidis DS, et al. Enhanced laparoscopic visualization of the extrahepatic bile duct with intravenous indocyanine green [abstract]. Am J Gastroenterol 1993; 88:1583.
- Vaughan J, Gurusamy KS, Davidson BR. Day-surgery versus overnight stay surgery for laparoscopic cholecystectomy. Cochrane Database Syst Rev 2013; :CD006798.
- Vaughan J, Nagendran M, Cooper J, et al. Anaesthetic regimens for day-procedure laparoscopic cholecystectomy. Cochrane Database Syst Rev 2014; :CD009784.
- Rao A, Polanco A, Qiu S, et al. Safety of outpatient laparoscopic cholecystectomy in the elderly: analysis of 15,248 patients using the NSQIP database. J Am Coll Surg 2013; 217:1038.
- Jaunoo SS, Mohandas S, Almond LM. Postcholecystectomy syndrome (PCS). Int J Surg 2010; 8:15.
- Girometti R, Brondani G, Cereser L, et al. Post-cholecystectomy syndrome: spectrum of biliary findings at magnetic resonance cholangiopancreatography. Br J Radiol 2010; 83:351.
- Lamberts MP, Den Oudsten BL, Gerritsen JJ, et al. Prospective multicentre cohort study of patient-reported outcomes after cholecystectomy for uncomplicated symptomatic cholecystolithiasis. Br J Surg 2015; 102:1402.
- van Dijk AH, Wennmacker SZ, de Reuver PR, et al. Restrictive strategy versus usual care for cholecystectomy in patients with gallstones and abdominal pain (SECURE): a multicentre, randomised, parallel-arm, non-inferiority trial. Lancet 2019; 393:2322.
- Latenstein CSS, Wennmacker SZ, van Dijk AH, et al. Cost-effectiveness of Restrictive Strategy Versus Usual Care for Cholecystectomy in Patients With Gallstones and Abdominal Pain (SECURE-trial). Ann Surg 2022; 276:e93.
Topic 3685 Version 48.0